DCNS has formally signed on as a supporting industry participant with Australia’s Defence Materials Technology Centre (DMTC).
The agreement will see DMTC and DCNS collaborate on developing technical expertise and building industrial capacity within Australian maritime sector supply chains, with a focus in the first instance on naval shipbuilding and repair.
DMTC industry partner Anteo Diagnostics Ltd has notified the ASX of the successful completion of the first milestone in their DMTC project, with initial studies demonstrating high-detection sensitivity.
Anteo has partnered with Planet Innovation, Deakin University and DMTC to further the technology readiness of Planet Innovation’s (Nplex) low cost, high sensitivity point of care diagnostic system using breakthrough reader technology.
Anteo’s contribution and objectives in Milestone 1 were to successfully functionalise nanoparticles requiring integration with Planet Innovation’s reader. Anteo has successfully established, optimised and verified a model lateral flow system for the nominated target assay using Mix&Go.
Work on the next milestone is already underway and is scheduled to be completed by next quarter.
The DMTC Medical Countermeasures (MCM) program recognises the increasingly important need to create, in Australia, an integrated multidisciplinary network focused on MCM product development.
DMTC’s Annual Conference will be held on 28 and 29 March 2017, in Canberra. our Annual Conference is an important opportunity to learn about the latest advances in technologies and priority industry capabilities within the DMTC community. The DMTC Gala Dinner will again be held as part of the Conference, including the presentation of the esteemed Awards of Excellence.
Further information will be made available in due course. DMTC looks forward to seeing you there.
